Skip to content
10-Q/A

Quarterly Report

AVID BIOSERVICES, INC.

0001683168-24-002658

← back to feed
Filed
Apr 24, 2024 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Aug 18, 2023 63.11M sh
Shares Diluted Q1 2024 · Jul 31, 2023 62.84M sh
Shares Diluted Q1 2024 · Jul 31, 2022 63.33M sh
Capex restated Q1 2024 · Jul 31, 2023 $14.16M
Capex restated Q1 2024 · Jul 31, 2022 $6.87M
Operating Cash Flow restated Q1 2024 · Jul 31, 2023 −$236K
Operating Cash Flow restated Q1 2024 · Jul 31, 2022 −$5.09M
Long Term Debt Q1 2024 · Jul 31, 2023 $48.6M
Cash And Equivalents Q1 2024 · Jul 31, 2023 $24.9M
Cash And Equivalents Q1 2024 · Apr 30, 2023 $38.54M
Cash And Equivalents Q1 2024 · Jul 31, 2022 $115.14M
Cash And Equivalents Q1 2024 · Apr 30, 2022 $126.17M
Stockholders Equity restated Q1 2024 · Jul 31, 2023 $190.27M
Stockholders Equity restated Q1 2024 · Apr 30, 2023 $189.17M
Stockholders Equity restated Q1 2024 · Jul 31, 2022 $178.8M
Stockholders Equity Q1 2024 · Apr 30, 2022 $174.53M
Current Liabilities restated Q1 2024 · Jul 31, 2023 $205.94M
Current Liabilities restated Q1 2024 · Apr 30, 2023 $215.15M
Total Liabilities restated Q1 2024 · Jul 31, 2023 $252.74M
Total Liabilities restated Q1 2024 · Apr 30, 2023 $262.4M
Current Assets Q1 2024 · Jul 31, 2023 $98.32M
Current Assets Q1 2024 · Apr 30, 2023 $112.45M
Total Assets restated Q1 2024 · Jul 31, 2023 $443.01M
Total Assets restated Q1 2024 · Apr 30, 2023 $451.57M
Eps Diluted Q1 2024 · Jul 31, 2023 −$0.03
Eps Diluted Q1 2024 · Jul 31, 2022 $0.02
Eps Basic Q1 2024 · Jul 31, 2023 −$0.03
Eps Basic restated Q1 2024 · Jul 31, 2022 $0.02
Sga Expense Q1 2024 · Jul 31, 2023 $6.26M
Sga Expense Q1 2024 · Jul 31, 2022 $6.38M
Net Income restated Q1 2024 · Jul 31, 2023 −$2.12M
Net Income restated Q1 2024 · Jul 31, 2022 $1.36M
Operating Income Q1 2024 · Jul 31, 2023 −$2.16M
Operating Income Q1 2024 · Jul 31, 2022 $2.74M
Gross Profit Q1 2024 · Jul 31, 2023 $4.1M
Gross Profit Q1 2024 · Jul 31, 2022 $9.12M
Revenue Q1 2024 · Jul 31, 2023 $37.73M
Revenue Q1 2024 · Jul 31, 2022 $36.69M